Supplementary Table 3 from Temporal Molecular and Biological Assessment of an Erlotinib-Resistant Lung Adenocarcinoma Model Reveals Markers of Tumor Progression and Treatment Response

crossref(2023)

引用 0|浏览16
暂无评分
摘要

XLS file - 395K, Identities of all metabolites detected, grouped by class of compound

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要